{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:06:05Z","timestamp":1793023565780,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007672","name":"Charles University in Prague Faculty of Medicine in Pilsen","doi-asserted-by":"publisher","award":["FN 00669806"],"award-info":[{"award-number":["FN 00669806"]}],"id":[{"id":"10.13039\/100007672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.anndiagpath.2025.152517","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:51:07Z","timestamp":1749523867000},"page":"152517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reactivity of carbonic anhydrase IX (CA IX) across the spectrum of renal cell carcinomas with sarcomatoid differentiation"],"prefix":"10.1016","volume":"79","author":[{"given":"Maryna","family":"Slisarenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Alaghehbandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Rogala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Farcas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Skopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Svajdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Petr","family":"Str\u00e1nsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriena Bartos","family":"Vesela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Pitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Hora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Pivovarcikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152517_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-200404000-00002","article-title":"Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome","volume":"28","author":"Cheville","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0010","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.juro.2009.07.049","article-title":"Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?","volume":"182","author":"Shuch","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0015","series-title":"Clear cell renal cell carcinoma. WHO Classification of Tumours Editorial Board. Urinary and male genital tumours","volume":"8","author":"Tan","year":"2022"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/his.14204","article-title":"Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes","volume":"77","author":"Baniak","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.hoc.2023.04.019","article-title":"Renal cell carcinoma of variant histology: biology and therapies","volume":"37","author":"Msaouel","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clgc.2014.12.001","article-title":"Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma","volume":"13","author":"Kim","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0035","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.euo.2024.02.007","article-title":"Stratification of patients with renal cell carcinoma by the abundance of Sarcomatoid features reveals differences in survival and the underlying pathobiology","volume":"7","author":"Salgia","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12885-017-3275-8","article-title":"Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0045","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.35141","article-title":"Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study)","volume":"155","author":"Ciccarese","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.10.019","article-title":"Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors","volume":"39","author":"Chahoud","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.21037\/atm-20-7009","article-title":"Renal cell carcinoma with non-clear cell histology or sarcomatoid differentiation: recent insight in an unmet clinical need","volume":"9","author":"Donskov","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0060","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071723","article-title":"The expression of carbonic anhydrases II, IX and XII in brain tumors","volume":"12","author":"Haapasalo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00405-011-1488-z","article-title":"Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis","volume":"268","author":"Peridis","year":"2011","journal-title":"Eur Arch Otorrinolaringol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0080","first-page":"7992","article-title":"Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer","volume":"61","author":"Giatromanolaki","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0090","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPVJDS28KNYZLD","article-title":"Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues","volume":"141","author":"Luong-Player","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2559.2011.04074.x","article-title":"Expression of carbonic anhydrase IX in genitourinary and adrenal tumours","volume":"59","author":"Donato","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAS.0b013e3181570343","article-title":"Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies","volume":"32","author":"Al-Ahmadie","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0110","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0000000000000258","article-title":"Members of the IIiDUPG. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Reuter","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPPPR57HNJMSLZ","article-title":"Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade","volume":"134","author":"Genega","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152517_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.juro.2006.11.100","article-title":"Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma","volume":"177","author":"Tickoo","year":"2007","journal-title":"J Urol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:11:45Z","timestamp":1755825105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S1092913425000826"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152517","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactivity of carbonic anhydrase IX (CA IX) across the spectrum of renal cell carcinomas with sarcomatoid differentiation","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152517"}}